ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Kyoto University's Center for iPS Cell Research and Application, or CiRA
Business

Japan's challenge: bringing iPS cell products to market

Lab error highlights the need for a strategy that includes the corporate sector

KIYOSHI ANDO, Nikkei senior staff writer | Japan

TOKYO -- It was a small mistake, but the repercussions were huge.

At Kyoto University's state-of-the-art Center for iPS Cell Research and Application (CiRA), a test tube was labeled incorrectly during the process of creating induced pluripotent stem cells, or iPS cells, from umbilical cord blood. The discovery, made in January, was a shock to the lab's researchers.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more